Latest Corporate News


Montreal, May 8, 2017 – Pharmascience inc., would like to announce the departure of its current Chief Operating Officer, Larry MacGirr effective May 31st, 2017. Larry will be moving back to Toronto to semi-retire and spend more time with his family.

“On behalf of myself, and all of us at Pharmascience, I wish to thank Larry for his passion, guidance, and commitment during our years of growth and successes’’ said David Goodman, Chief Executive Officer at Pharmascience inc.

Pharmascience is excited to announce the appointment of Jean-Guy Goulet as its new Chief Operating Officer. Jean-Guy will officially join the company on May 29, 2017.

“We are thrilled to welcome Jean-Guy to an already strong leadership team. Jean-Guy is a resilient and driven leader with a keen understanding of customer needs. His in depth expertise and knowledge of our industry will undoubtedly serve Pharmascience and its customers well’’ said David Goodman.

Prior to joining Pharmascience, Jean-Guy, an executive with more than 28 years of experience in the pharmaceutical industry, held many senior leadership roles including that of President of Actavis Canada.

 “I feel privileged and excited to join the Pharmascience team, a leader in our industry. I look forward to working with the team and our customers to ensure we remain a trusted partner of choice’’ said Jean-Guy.

The pharmaceutical industry has weathered a number of challenges in recent years. Through it all, Pharmascience, a Canadian based company headquartered in Montreal, has stood strong and has continued to invest heavily in its people and in modernizing its technology, equipment and installations to better serve its customers and patients in Canada and around the world.


About Pharmascience Inc.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with over 1500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 60 countries.  Ranked 57th among Canada’s top 100 R&D investors with over $44 million invested in 2015, Pharmascience Inc. is the 10th largest pharmaceutical company in Canada. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as the partner of choice to increase access to medicine. Pharmascience’s total donations of essential medicine, is close to $60 million. Pharmascience Inc. is a leading manufacturer and marketer of prescription; generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. Pharmascience Inc. commercializes nearly 400 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.

For more information, please visit 


Back to News